SYNBIOTIC SE
NuWays RecommendationRecommendation
Buy
Price Target
€5.50
Upside
66.16%
Chart
- 1M
- 3M
- 6M
- YTD
- 1Y
- 3Y
€3.31
-€0.05 (-1.34%)
Realtime-Data from 08.01.2025 08:00:00
SYNBIOTIC is a buy-and-build operator in the European industrial hemp, cannabis and cannabinoid market with an objective to establish a fully integrated platform-company with activities across the entire value chain from cultivation to production and retail.
ISIN
DE000A3E5A59
Market Cap
€19.82M
Enterprise Value
€22.89M
26 week avg vol.
5000
Primar Exchange
Xetra
IPO
2019
Sector
Health Care
Headquarters
Munich, DE
Employees
64
Incorporated
2015
CEO
Daniel Kruse
Website
Free Float
74.00%
NH mgmt GmbH
8.30%
Cancos GmbH
6.50%
Frank Otto
6.10%
HempConsult GmbH
5.10%
KPIs in EUR
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| Sales | 3.86M | 15.92M | 16.55M |
| EBITDA | -7.19M | -1.01M | -1.35M |
| EBIT | -11.75M | -2.13M | -2.43M |
| EPS | -2.12 | -0.30 | -0.32 |
| FCF | -2.94M | -4.33M | -55.91K |
Valuation
| KPI | 2023 | 2024e | 2025e |
|---|---|---|---|
| EV / Sales | 5.93x | 1.42x | 1.33x |
| EV / EBITDA | (3.18x) | (22.31x) | (16.29x) |
| EV / EBIT | (1.95x) | (10.63x) | (9.06x) |
| Price / Earnings | (1.56x) | (10.87x) | (10.39x) |
| EV / FCF | (7.78x) | (5.22x) | (394.30x) |
Downloads
Latest Research
Initiation